The Center for Technology Innovation at the Brookings Institution issues a report titled “Enabling Personalized Medicine through Health Information Technology,” that makes recommendations for making the United States a health care leader among those nations “moving forward with personalized medicine and health information technology.”

The Center for Law, Science & Innovation at the Sandra Day O’Connor College of Law at Arizona State University (ASU) schedules a national conference to “examine recent trends and challenges in regulation and risk management of nanotechnology.” The March 21, 2011, conference in Phoenix will feature national and international nanotechnology experts from government, industry, non-governmental organizations, the insurance industry, and academia.

Democratic Senators re-introduce a bill (S. 373) to stop brand-name drug makers from marketing authorized generic versions during the 180-day exclusivity window that follows the first successful challenge by a generic-drug manufacturer to a brand patent.